Monsanto asked to pay $2 billion for carcinogenic product
This is the third time in the last 10 months that Monsanto has been found guilty of manufacturing cancer-causing products, especially Roundup
Experts slam trial for new Bt brinjal variety, cite regulatory lapses
The Event 142 variety of genetically modified brinjal was quietly approved for field trials without any data in the public domain, claim experts